Pages with the fewest revisions

From The School of Biomedical Sciences Wiki
Jump to: navigation, search

Showing below up to 500 results starting with #501.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Daughter cells ‎(2 revisions)
  2. Exosome ‎(2 revisions)
  3. Diamond ‎(2 revisions)
  4. Infection ‎(2 revisions)
  5. Classification ‎(2 revisions)
  6. Malignancy ‎(2 revisions)
  7. Watson-Crick pairs ‎(2 revisions)
  8. Tendons ‎(2 revisions)
  9. Semiconservative replication ‎(2 revisions)
  10. Follicle stimulating hormone ‎(2 revisions)
  11. XYY syndrome ‎(2 revisions)
  12. Thomas Cech ‎(2 revisions)
  13. Signalling cascade ‎(2 revisions)
  14. Carbon monoxide ‎(2 revisions)
  15. Joseph lister ‎(2 revisions)
  16. Subst ‎(2 revisions)
  17. Gluten ‎(2 revisions)
  18. Primer ‎(2 revisions)
  19. Aluminium ‎(2 revisions)
  20. Properties of Action Potentials ‎(2 revisions)
  21. Innate immune response ‎(2 revisions)
  22. Proteoglycan ‎(2 revisions)
  23. Domain ‎(2 revisions)
  24. Sertraline ‎(2 revisions)
  25. Y-linked disorders ‎(2 revisions)
  26. Antithrombin III ‎(2 revisions)
  27. EcoR1 ‎(2 revisions)
  28. Phosphoenolpyruvate ‎(2 revisions)
  29. Ketose ‎(2 revisions)
  30. Transgenic bacteria ‎(2 revisions)
  31. Acetyl group ‎(2 revisions)
  32. Endocrine glands ‎(2 revisions)
  33. Spermatozoa ‎(2 revisions)
  34. Enzyme-linked receptors ‎(2 revisions)
  35. Leber Congenital Amaurosis ‎(2 revisions)
  36. Aerobic ‎(2 revisions)
  37. Erythrocytes ‎(2 revisions)
  38. Ubiquitin-activating enzyme E3 ‎(2 revisions)
  39. Alkylation ‎(2 revisions)
  40. Glycogen synthesis ‎(2 revisions)
  41. Immunogold labelling ‎(2 revisions)
  42. Systolic pressure ‎(2 revisions)
  43. Necrotising fasciitis ‎(2 revisions)
  44. Anaerobic respiration ‎(2 revisions)
  45. Neurons ‎(2 revisions)
  46. Secondary messenger ‎(2 revisions)
  47. CFTR channel ‎(2 revisions)
  48. Flagellum ‎(2 revisions)
  49. Wuchereria bancrofti ‎(2 revisions)
  50. Canis familiaris ‎(2 revisions)
  51. Electrically exciteable cells ‎(2 revisions)
  52. Tolerance ‎(2 revisions)
  53. Corpus luteum ‎(2 revisions)
  54. High blood pressure ‎(2 revisions)
  55. Mitogens ‎(2 revisions)
  56. Tricyclic antidepressants ‎(2 revisions)
  57. Acyl group ‎(2 revisions)
  58. Monoploidy ‎(2 revisions)
  59. Basal bodies ‎(2 revisions)
  60. Lymphomas ‎(2 revisions)
  61. Prolactin ‎(2 revisions)
  62. Passive transporter ‎(2 revisions)
  63. TFIIA ‎(2 revisions)
  64. Growth factor receptor ‎(2 revisions)
  65. Bovine spongiform encephalopathy ‎(2 revisions)
  66. X Chromosome Inactivation ‎(2 revisions)
  67. Connexins ‎(2 revisions)
  68. Arteriole ‎(2 revisions)
  69. Photoreceptors ‎(2 revisions)
  70. Histone Acetyltransferases ‎(2 revisions)
  71. Cation channels ‎(2 revisions)
  72. Centromeres ‎(2 revisions)
  73. Oxidative damage ‎(2 revisions)
  74. Basophils ‎(2 revisions)
  75. Eukaryotic ‎(2 revisions)
  76. Imidazole ‎(2 revisions)
  77. Amylase ‎(2 revisions)
  78. T lymphocyte ‎(2 revisions)
  79. Anomer ‎(2 revisions)
  80. Complementary base pairing ‎(2 revisions)
  81. Mesoderm ‎(2 revisions)
  82. Isoelectric Point ‎(2 revisions)
  83. Microbiota ‎(2 revisions)
  84. Elute ‎(2 revisions)
  85. Placenta ‎(2 revisions)
  86. Transgenic mice ‎(2 revisions)
  87. Genetic disorders ‎(2 revisions)
  88. Multipotent ‎(2 revisions)
  89. Bacterial meningitis ‎(2 revisions)
  90. Myosin light chain kinase ‎(2 revisions)
  91. T-Lymphocyte ‎(2 revisions)
  92. Cis-regulatory element ‎(2 revisions)
  93. Nedd4 ‎(2 revisions)
  94. Capillaries ‎(2 revisions)
  95. Phosphoric acid ‎(2 revisions)
  96. Corticosteroids ‎(2 revisions)
  97. High density lipoproteins ‎(2 revisions)
  98. Sodium-calcium Exchanger ‎(2 revisions)
  99. Rate of reaction ‎(2 revisions)
  100. Pluripotent stem cells ‎(2 revisions)
  101. Epigenome ‎(2 revisions)
  102. Loci ‎(2 revisions)
  103. IPTG ‎(2 revisions)
  104. Amniocentisis ‎(2 revisions)
  105. Patau's Syndrome ‎(2 revisions)
  106. Bowman's capsule ‎(2 revisions)
  107. Female ‎(2 revisions)
  108. Termination ‎(2 revisions)
  109. Column chromatography ‎(2 revisions)
  110. Ca2+ ions ‎(2 revisions)
  111. Antigenic variation ‎(2 revisions)
  112. Heredity ‎(2 revisions)
  113. GABA receptors ‎(2 revisions)
  114. Methyl ‎(2 revisions)
  115. K+ leak channel ‎(2 revisions)
  116. Absorbance ‎(2 revisions)
  117. Poly-A tail ‎(3 revisions)
  118. Trisomy 18 ‎(3 revisions)
  119. D-glucose ‎(3 revisions)
  120. Hypertonic solution ‎(3 revisions)
  121. Glyceraldehyde ‎(3 revisions)
  122. Chromosome 4 ‎(3 revisions)
  123. Naproxen ‎(3 revisions)
  124. Blood stream ‎(3 revisions)
  125. Prophase I ‎(3 revisions)
  126. Amyloid ‎(3 revisions)
  127. T lymphocytes ‎(3 revisions)
  128. CoA ‎(3 revisions)
  129. HCAs ‎(3 revisions)
  130. Mesophyll cell ‎(3 revisions)
  131. Thyroid stimulating hormone ‎(3 revisions)
  132. Heterozygotes ‎(3 revisions)
  133. Nuclear fission ‎(3 revisions)
  134. GPCR ‎(3 revisions)
  135. Transition State ‎(3 revisions)
  136. Oligomer ‎(3 revisions)
  137. Sphingosine ‎(3 revisions)
  138. Allele ‎(3 revisions)
  139. Lymph ‎(3 revisions)
  140. Impetigo ‎(3 revisions)
  141. Parasite ‎(3 revisions)
  142. Negative charge ‎(3 revisions)
  143. Fas signalling ‎(3 revisions)
  144. Insertional inactivation ‎(3 revisions)
  145. Secretory vesicle ‎(3 revisions)
  146. Fluid mosaic model ‎(3 revisions)
  147. RNA interference ‎(3 revisions)
  148. Electrochemical gradient ‎(3 revisions)
  149. Mitotic spindle ‎(3 revisions)
  150. Adaptive immune system ‎(3 revisions)
  151. Human genome ‎(3 revisions)
  152. Glucose transporter ‎(3 revisions)
  153. Deacetylation ‎(3 revisions)
  154. Idiopathic ‎(3 revisions)
  155. Sympathetic nervous system ‎(3 revisions)
  156. Females ‎(3 revisions)
  157. Ipatropium ‎(3 revisions)
  158. Carboxyl ‎(3 revisions)
  159. Homo erectus ‎(3 revisions)
  160. Hydrocarbons ‎(3 revisions)
  161. Glyceraldehyde-3-phosphate ‎(3 revisions)
  162. Paneth cell ‎(3 revisions)
  163. Narcolepsy ‎(3 revisions)
  164. F-plasmid ‎(3 revisions)
  165. MAP kinase kinase ‎(3 revisions)
  166. Wildtype ‎(3 revisions)
  167. Phosphoglycerides ‎(3 revisions)
  168. Nuclear lamina ‎(3 revisions)
  169. Cardiac cycle ‎(3 revisions)
  170. GRB2 ‎(3 revisions)
  171. Enzyme active site ‎(3 revisions)
  172. Legionella pneumophila ‎(3 revisions)
  173. Polymerisation ‎(3 revisions)
  174. Hydrolases ‎(3 revisions)
  175. Rosalind Franklin ‎(3 revisions)
  176. Bile ‎(3 revisions)
  177. Importins ‎(3 revisions)
  178. Neutrino ‎(3 revisions)
  179. The central dogma ‎(3 revisions)
  180. Gametocytes ‎(3 revisions)
  181. Endosomes ‎(3 revisions)
  182. Point mutation ‎(3 revisions)
  183. Oogenesis ‎(3 revisions)
  184. Alcohol group ‎(3 revisions)
  185. Glucuronidation ‎(3 revisions)
  186. Glycosyltransferase ‎(3 revisions)
  187. Dideoxynucleotide ‎(3 revisions)
  188. TFIIE ‎(3 revisions)
  189. Hayflick Limit ‎(3 revisions)
  190. Ca2+ signalling toolkit ‎(3 revisions)
  191. Thrombin ‎(3 revisions)
  192. Hess's Law ‎(3 revisions)
  193. Karyogram ‎(3 revisions)
  194. Transducin(Gt) ‎(3 revisions)
  195. Accession number ‎(3 revisions)
  196. Histone deacetylases ‎(3 revisions)
  197. Transition mutation ‎(3 revisions)
  198. Acetyltransferase ‎(3 revisions)
  199. Homo sapiens ‎(3 revisions)
  200. Organ of corti ‎(3 revisions)
  201. Mucus ‎(3 revisions)
  202. Postsynaptic cell ‎(3 revisions)
  203. Vacuole ‎(3 revisions)
  204. Amide bond ‎(3 revisions)
  205. Syncytium ‎(3 revisions)
  206. Medulla ‎(3 revisions)
  207. Fructose-1,6-bisphosphate ‎(3 revisions)
  208. AMP ‎(3 revisions)
  209. Coomassie blue ‎(3 revisions)
  210. Heterozygous advantage ‎(3 revisions)
  211. Ran-GAP ‎(3 revisions)
  212. Cell lysis ‎(3 revisions)
  213. Polymers ‎(3 revisions)
  214. DNA Structure ‎(3 revisions)
  215. Muscarinic acetylcholine receptor ‎(3 revisions)
  216. Dalton ‎(3 revisions)
  217. Chloroplast ‎(3 revisions)
  218. Progesterone ‎(3 revisions)
  219. Bombay Phenotype ‎(3 revisions)
  220. Coenzyme Q ‎(3 revisions)
  221. Melanoma ‎(3 revisions)
  222. Heparin ‎(3 revisions)
  223. Arcoxia ‎(3 revisions)
  224. Hippocampus ‎(3 revisions)
  225. Endosymbiont theory ‎(3 revisions)
  226. Humans ‎(3 revisions)
  227. Ribonucleic acid ‎(3 revisions)
  228. Logarithm ‎(3 revisions)
  229. Urethra ‎(3 revisions)
  230. Alpha-carbon ‎(3 revisions)
  231. Decarboxylation ‎(3 revisions)
  232. Glycosyltransferases ‎(3 revisions)
  233. Villi ‎(3 revisions)
  234. Clonal selection ‎(3 revisions)
  235. Anhydrides ‎(3 revisions)
  236. Electrophoretic mobility shift assay ‎(3 revisions)
  237. Histone variants ‎(3 revisions)
  238. Cuvette ‎(3 revisions)
  239. Le Chatelier's Principle ‎(3 revisions)
  240. Organelle ‎(3 revisions)
  241. Glial cell ‎(3 revisions)
  242. Blood vessel ‎(3 revisions)
  243. Vitamin K ‎(3 revisions)
  244. HDL ‎(3 revisions)
  245. Second Law of Thermodynamics ‎(3 revisions)
  246. Wilson's disease ‎(3 revisions)
  247. Anti-parallel ‎(3 revisions)
  248. Metabolic pathway ‎(3 revisions)
  249. Quaternary structures ‎(3 revisions)
  250. Aptamer ‎(3 revisions)
  251. Edward's syndrome ‎(3 revisions)
  252. Hexokinase ‎(3 revisions)
  253. Microtuble ‎(3 revisions)
  254. Ran GTPase ‎(3 revisions)
  255. Aster ‎(3 revisions)
  256. Empirical formula ‎(3 revisions)
  257. Hormone ‎(3 revisions)
  258. Eosinophil ‎(3 revisions)
  259. Charge ‎(3 revisions)
  260. BamHI ‎(3 revisions)
  261. Amino group ‎(3 revisions)
  262. COP II ‎(3 revisions)
  263. Melting point ‎(3 revisions)
  264. X-ray crystallography ‎(3 revisions)
  265. Mismatch Repair ‎(3 revisions)
  266. Solution ‎(3 revisions)
  267. Gel filtration chromatography ‎(3 revisions)
  268. Cytoplasmic membrane ‎(3 revisions)
  269. SsDNA ‎(3 revisions)
  270. BRCA2 ‎(3 revisions)
  271. Aldehyde ‎(3 revisions)
  272. Ovulation ‎(3 revisions)
  273. Fibrin ‎(3 revisions)
  274. Animal ‎(3 revisions)
  275. Compartmentation ‎(3 revisions)
  276. Antioxidant ‎(3 revisions)
  277. Norepinephrine ‎(3 revisions)
  278. Single stranded binding protein ‎(3 revisions)
  279. R groups ‎(3 revisions)
  280. Plantae ‎(3 revisions)
  281. Offspring ‎(3 revisions)
  282. Le Chatelier's principle ‎(3 revisions)
  283. Glial cells ‎(3 revisions)
  284. Succinyl CoA ‎(3 revisions)
  285. Myocardial infarction ‎(3 revisions)
  286. Beta-oxidation ‎(3 revisions)
  287. Protium ‎(3 revisions)
  288. Anti-parallel beta sheet ‎(3 revisions)
  289. Aquaporin ‎(3 revisions)
  290. Phospholipases ‎(3 revisions)
  291. Asters ‎(3 revisions)
  292. Atoms ‎(3 revisions)
  293. Cystic fibrosis-related diabetes ‎(3 revisions)
  294. Eosinophils ‎(3 revisions)
  295. Leptotene ‎(3 revisions)
  296. P21 ‎(3 revisions)
  297. Vena cava ‎(3 revisions)
  298. Flux ‎(3 revisions)
  299. Thermophile ‎(3 revisions)
  300. Jaundice ‎(3 revisions)
  301. Phosphorylase kinase ‎(3 revisions)
  302. A b toxin ‎(3 revisions)
  303. Nucleophile ‎(3 revisions)
  304. Sodium acetate ‎(3 revisions)
  305. Null mutation ‎(3 revisions)
  306. Autoimmune disorder ‎(3 revisions)
  307. Triple bond ‎(3 revisions)
  308. Ribonucleoproteins ‎(3 revisions)
  309. Base pairing ‎(3 revisions)
  310. Chromosomal inversion ‎(3 revisions)
  311. Viral meningitis ‎(3 revisions)
  312. Weismann's experiment ‎(3 revisions)
  313. Interpro ‎(3 revisions)
  314. Test crosses ‎(3 revisions)
  315. Competitive antagonist ‎(3 revisions)
  316. Menstrual cycle ‎(3 revisions)
  317. Islet Amyloidosis ‎(3 revisions)
  318. Phosphocreatine ‎(3 revisions)
  319. Normal flora ‎(3 revisions)
  320. Plants ‎(3 revisions)
  321. Acidosis ‎(3 revisions)
  322. Le chateliers principle ‎(3 revisions)
  323. Tritium ‎(3 revisions)
  324. Organic chemistry ‎(3 revisions)
  325. Bacterial cells ‎(3 revisions)
  326. UV-Vis Spectrophotometry ‎(3 revisions)
  327. Prostaglandin ‎(3 revisions)
  328. The Holliday Model of DNA cossover ‎(3 revisions)
  329. Zinc finger ‎(3 revisions)
  330. Edwards syndrome ‎(3 revisions)
  331. Core histones ‎(3 revisions)
  332. Polynucleotide Chain ‎(3 revisions)
  333. Lipoproteins ‎(3 revisions)
  334. Allery to Eggs ‎(3 revisions)
  335. Vena cavae ‎(3 revisions)
  336. Griffith experiment ‎(3 revisions)
  337. Bone marrow ‎(3 revisions)
  338. Major histocompatibility complex ‎(3 revisions)
  339. Watson-Crick ‎(3 revisions)
  340. Thermostable ‎(3 revisions)
  341. G0 phase ‎(3 revisions)
  342. RNA primer ‎(3 revisions)
  343. Transamination ‎(3 revisions)
  344. Sodium chloride ‎(3 revisions)
  345. Huntington's disease ‎(3 revisions)
  346. Ligand-gated sodium channels ‎(3 revisions)
  347. Eukarya ‎(3 revisions)
  348. Alpha carbon ‎(3 revisions)
  349. NMDA receptor ‎(3 revisions)
  350. Initiation factor ‎(3 revisions)
  351. Bromodomains ‎(3 revisions)
  352. Mass spectrometry ‎(3 revisions)
  353. Nitric oxide ‎(3 revisions)
  354. Frameshift mutation ‎(3 revisions)
  355. Menstruation ‎(3 revisions)
  356. Normality ‎(3 revisions)
  357. Carboxylic acid group ‎(3 revisions)
  358. Kernicterus ‎(3 revisions)
  359. Cell Lysis ‎(3 revisions)
  360. Regulator gene ‎(3 revisions)
  361. Hydrogen bond ‎(3 revisions)
  362. Global warming ‎(3 revisions)
  363. Sugar ‎(3 revisions)
  364. Beta Barrel ‎(3 revisions)
  365. Diplococci ‎(3 revisions)
  366. Fischer projection ‎(3 revisions)
  367. Proton gradient ‎(3 revisions)
  368. Receptor-mediated endocytosis ‎(3 revisions)
  369. B-cells ‎(3 revisions)
  370. Epidermis ‎(3 revisions)
  371. Estrogen receptor ‎(3 revisions)
  372. Diagnosis ‎(3 revisions)
  373. Nephrogenic diabetes insipidus ‎(3 revisions)
  374. Protein domain ‎(3 revisions)
  375. Half life ‎(3 revisions)
  376. RNA synthesis ‎(3 revisions)
  377. Gap junctions ‎(3 revisions)
  378. Ligand gated ion channels ‎(3 revisions)
  379. DNA repair ‎(3 revisions)
  380. Hyperpolarisation ‎(3 revisions)
  381. Eukaryota ‎(3 revisions)
  382. Long terminal receptor ‎(3 revisions)
  383. Deletion mutation ‎(3 revisions)
  384. Ileum ‎(3 revisions)
  385. PTBI ‎(3 revisions)
  386. Amphiphatic ‎(3 revisions)
  387. Digestion ‎(3 revisions)
  388. Schizophrenia ‎(3 revisions)
  389. Interstitial fluids ‎(3 revisions)
  390. Heart Attack ‎(3 revisions)
  391. Antisense DNA ‎(3 revisions)
  392. Thymus ‎(3 revisions)
  393. Ketamine ‎(3 revisions)
  394. Reiji Okazaki ‎(3 revisions)
  395. Enzyme-Substrate Complex ‎(3 revisions)
  396. Leaves ‎(3 revisions)
  397. Polygenic disease ‎(3 revisions)
  398. Organic molecules ‎(3 revisions)
  399. Retinoblastoma protein ‎(3 revisions)
  400. Bacterial chromosomes ‎(3 revisions)
  401. Potassium ions ‎(3 revisions)
  402. Hypomagnesaemia ‎(3 revisions)
  403. Chiral centre ‎(3 revisions)
  404. Factor independent termination ‎(3 revisions)
  405. Inositol 1,4,5-trisphosphate ‎(3 revisions)
  406. H index ‎(3 revisions)
  407. Anti parallel strands ‎(3 revisions)
  408. Nuclear receptors ‎(3 revisions)
  409. Cell signalling molecules ‎(3 revisions)
  410. Genetic variation ‎(3 revisions)
  411. Osmoreceptors ‎(3 revisions)
  412. Unit of Enzyme ‎(3 revisions)
  413. Svedberg unit ‎(3 revisions)
  414. Glycosaminoglycan ‎(3 revisions)
  415. Growth Hormone ‎(3 revisions)
  416. Fatty acids ‎(3 revisions)
  417. Protein folding ‎(3 revisions)
  418. Integral membrane proteins ‎(3 revisions)
  419. Follicle-stimulating Hormone ‎(3 revisions)
  420. Photo 51 ‎(3 revisions)
  421. Abdomen ‎(3 revisions)
  422. Molality ‎(3 revisions)
  423. Reciprocal translocation ‎(3 revisions)
  424. Lamellipodia ‎(3 revisions)
  425. Centrioles ‎(3 revisions)
  426. Ligands ‎(3 revisions)
  427. Longterm potentiation ‎(3 revisions)
  428. Urine ‎(3 revisions)
  429. Golgi apparatus ‎(3 revisions)
  430. Guanosine diphosphate ‎(3 revisions)
  431. Neuraminidase ‎(3 revisions)
  432. Serotype ‎(3 revisions)
  433. Nuclear dimorphism ‎(3 revisions)
  434. Plasma cell ‎(3 revisions)
  435. Sacromere ‎(3 revisions)
  436. Facultative heterochromatin ‎(3 revisions)
  437. Protazoa ‎(3 revisions)
  438. Metabolome ‎(3 revisions)
  439. Zwitterion ‎(3 revisions)
  440. Coronary artery ‎(3 revisions)
  441. Nuclear spallation ‎(3 revisions)
  442. Carrier protein ‎(3 revisions)
  443. LacY gene ‎(3 revisions)
  444. Pluripotent embryonic stem cells ‎(3 revisions)
  445. Tricarboxylic Acid ‎(3 revisions)
  446. Oncology ‎(3 revisions)
  447. DNA ladder ‎(3 revisions)
  448. Chemical bonds ‎(3 revisions)
  449. Muscle hypertrophy ‎(3 revisions)
  450. Rho independent terminators ‎(3 revisions)
  451. IP3 receptor ‎(3 revisions)
  452. Glycosdic bond ‎(3 revisions)
  453. TATA promoter ‎(3 revisions)
  454. Periplasmic space ‎(3 revisions)
  455. Antigen receptor ‎(3 revisions)
  456. Phosphate groups ‎(3 revisions)
  457. Abnormal Processing ‎(3 revisions)
  458. Cation ‎(3 revisions)
  459. Molar ‎(3 revisions)
  460. Laminin ‎(3 revisions)
  461. Oxidation number ‎(3 revisions)
  462. Imatinib ‎(3 revisions)
  463. Visible light ‎(3 revisions)
  464. Co-dominant ‎(3 revisions)
  465. Neuroanatomy ‎(3 revisions)
  466. Anode ‎(3 revisions)
  467. Merozoites ‎(3 revisions)
  468. Isocitrate dehydrogenase ‎(3 revisions)
  469. Heterotroph ‎(3 revisions)
  470. Nuclear division ‎(3 revisions)
  471. Radioactive ‎(3 revisions)
  472. Auxins ‎(3 revisions)
  473. Amino acid ‎(3 revisions)
  474. Codons ‎(3 revisions)
  475. Hemi-desmosomes ‎(3 revisions)
  476. Metagenomics ‎(3 revisions)
  477. Arachidonic acid ‎(3 revisions)
  478. Phospholipids ‎(3 revisions)
  479. Midbrain ‎(3 revisions)
  480. Atrophy ‎(3 revisions)
  481. LacZα gene ‎(3 revisions)
  482. Genome ‎(3 revisions)
  483. Glucose 6-phosphate ‎(3 revisions)
  484. Liver X receptor ‎(3 revisions)
  485. Sweat Gland ‎(3 revisions)
  486. NADP ‎(3 revisions)
  487. Amnesia ‎(3 revisions)
  488. Clatharin ‎(3 revisions)
  489. Nernst equation ‎(3 revisions)
  490. Nicotinamide ‎(3 revisions)
  491. C value paradox ‎(3 revisions)
  492. Formative Assessment ‎(3 revisions)
  493. Antigenic drift ‎(3 revisions)
  494. Ions ‎(3 revisions)
  495. Phosphates ‎(3 revisions)
  496. Transcription Factor H ‎(3 revisions)
  497. Crystal violet ‎(3 revisions)
  498. Obestiy ‎(3 revisions)
  499. Recombinant DNA technology ‎(3 revisions)
  500. Autophosphorylate ‎(3 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

Personal tools
Namespaces
Variants
Views
Actions
Navigation
Toolbox